Health-related quality of life and blood pressure control in hypertensive patients with and without complications

Clinics

Volumn 64, Issue 7, 2009, Pages 619-628

  de Gusmão, Josiane Lima ^a   Mion Jr , Decio ^a   Pierin, Angela Maria Geraldo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood pressure control; Educational; Health related quality of life; Hypertension; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE; BRAZIL; CHI SQUARE DISTRIBUTION; DRUG EFFECT; FEMALE; FITNESS; HEALTH STATUS; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; STANDARD; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAZIL; CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH STATUS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHYSICAL FITNESS; QUALITY OF LIFE; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 69149110052     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009000700003     Document Type: Article

References (42)

1. Mion Jr. D, Praxedes JN, Amodeo C, Gomes MAM, Machado CA, Gusmão JL, et al. V Brazilian Guidelines in Arterial Hypertension. Arq Bras Cardiol. 2007; 89:e24-e79.
2. Hamet P. The burden of blood pressure: where are we and where should we go? Can Cardiol. 2000;16:1483-7.
3. Vega CE, Kahhale S, Zugaib M. Maternal mortality due to arterial hypertension in São Paulo City (1995-1999). Clinics. 2007;62:679-84.
4. Martinelli LM, Mizutani BM, Mutti A, D'elia MP, Coltro RS, Matsubara BB. Quality of life and its association with cardiovascular risk factors in a community health care program population. Clinics. 2008;63:783-8.
5. Bocalini DS, dos Santos L, Serra AJ. Physical exercise improves the functional capacity and quality of life in patients with heart failure. Clinics. 2008;63:437-42.
6. Pierin AM, Ignez EC, Jacob Filho W, Barbato AJ, Mion Jr D. Blood pressure measurements taken by patients are similar to home and ambulatory blood pressure measurements. Clinics. 2008;63:43-50.
7. Prospectives Studies Collaboration. Cholesterol, disatolic blood pressure and stroke: 13.000 strokes in 450.000 people in 45 prospectives cohorts. Lancet 1995;346:1647-53.
8. Coca A. Actual blood pressure control: are we doing things right? J Hypertens 1998;16:S45-51.
9. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA. 2003;289:2560-72.
10. Fagard RH, Van den Enden M. Treatment and blood pressure control in isolated systolic hypertension vs diastolic hypertension in primary care. J Hum Hypertens 2003;17:681-7.
11. Cifkova R, Skodova Z, Lanska V, Adamkova V, Novozamska E, Jozifova M, et al. Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study. J Hum Hypertens. 2004;18:571-9.
12. Bharucha NE, Kuruvilla T. Hypertension in the Parsi community of Bombay: a study on prevalence, awareness and compliance to treatment. BioMed Central Public Health. 2003;3:1. Epub 2003.
13. Fodor JG, Lietava J, Rieder A, Sonkodi S, Stokes H, Emmons T, et al. Work-site hypertension prevalence and control in three Central European Countries. J Hum Hypertens. 2004;18:581-5.
14. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR., Giampaoli S, Joffres MR, et al. Hypertension Treatment and Control in Five European Countries, Canada, and the United States. Hypertension. 2004;43:10-17.
15. Wheltom P K, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens. 2004; 18:545-51.
16. Sarafidis PA, Lasaridis A, Gousopoulos S, Zebekakis P, Nikolaidis P, Tziolas I, et al. Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study. J Hum Hypertension. 2004;18:623-29.
17. Piccini RX, Victoria CG. How well is hypertension managed in the community? A population-based srvey in a Brazilian city. Cad Saude Publica. 1997;17:151-83.
18. Gus I, Harzheim E, Zaslavsky C, Medina C, Gus M. Prevalence, awareness, and control of systemic arterial hypertension in the state of Rio Grande do Sul. Arq Bras Cardiol. 2004;83:424-28.
19. Strelec MAAM, Pierin AMG, Mion Jr. D. The Influence of Patient's Consciousness Regarding High Blood Pressure and Patient's Attitude in Face of Disease Controlling Medicine Intake. Arq Bras Cardiol. 2003;81:349-54.
20. Fletcher A. Quality of life in the management of hypertension. Clin and Exper Hypertension. 1999;21:961-72.
21. Bulpitt CJ, Dollery CT, Carne S. Change in symptoms of hypertension patients after referral to hospital clinic. Br Heart J. 1976;38:121-8.
22. Plaisted CS, Lin P-H, Ard JD, McClure ML, Svetkey LP. The effects of dietary patterns on quality of life: a substudy of the Dietary Approaches to Stop Hypertension trial. J Am Diet Assoc.. 1999;99:S84-S89.
23. Batey DM, Kaufmann PG, Raczinski JM, Hollis JF, Murphy JK, Rosner B. Stress management intervention for primary prevention of hypertension: detailed results from Phase I of Trials of Hypertension Prevention (TOHP-I). Ann Epidemiol. 2000;10:45-58.
24. Grimm Jr. RH, Grandits GA, Cutler JA, Stewart AL, McDonald RH, Svendsen K, et al.for the TOMHS Research Group. Relationships of quality of life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study (TOMHS). Arch Inter Med. 1997;157:638-48.
25. Bulpitt CJ, Fletcher AE. Quality of life instruments in hypertension. Pharmaco Economics. 1994;6:523-35.
26. Aydemir O, Ozdemir C, Koroglu E. The impact of co-morbid conditions on the SF-36: a primary-care-based study among patients. Arch Med Res. 2005; 36:136-41.
27. Mano GM, Souza VF, Pierin AM, Lima JC, Ignes EC, Ortega KC, et al. Assessment of the DIXTAL DX-2710 automated oscillometric device for blood pressure measurement with the validation protocols of the British Hypertension Society (BHS) and the Association for Advancement of Medical Instrumentation (AAMI). Arq Bras Cardiol. 2002;79:606-10.
28. Palmer AJ, Fletcher AE, Rudge PJ, Andrews CD, Callaghan S, Bulpitt CJ. Quality of life in patients treated with atenolol or captopril: a double-blind crossover trial. J Hypertens. 1992;10:1409-16.
29. Fletcher AE, Chester PC, Hawkins CMA, Latham AN, Pike LA, Bulpitt CJ. The effects of verapamil and propranolol on quality of life in hypertension. J Hum Hypertens. 1989;3:125-30.
30. Alonso J, Ferrer M, Gandek B, Ware Jr. J, Aaronson NK, Mosconi P, et al. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assesssment (IQOLA) Project. Qual Life Res. 2004;13:283-98.
31. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence (Cochrane Review). In: The Cochrane Library, Issue 3, 2008.
32. Nunes MI. The relationship between quality of life and adherence to treatment. Curr Hypertens Rep. 2001;3:462-5.
33. Erickson SR, Williams, Gruppen LD. Perceived symptoms and health-related quality of life reported by uncomplicated hypertensive patients compared to normal controls. J Hum Hyperetens. 2001;15:539-48.
34. Bardage C, Isacson D, Ring L, Bingefors. A swedish population-based study on the relationship between the SF-36 and health utilities to measure health in hypertension. Blood Press. 2003;12:203-10.
35. Hemingway H, Stafford M, Stansfeld S, Shipley M, Marmot M. Is the SF-36 a valid measure of change in population health? Results from the Whitehall II study. BMJ. 1997;315:1273-9.
36. Szirmai LA, Arnold C, Farsang C. Improving control of hypertension by an integrated approach - results of the "Manage it well" programme. J Hypertens. 2005;23:203-11.
37. Hanson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeidt D, Julius S, et al., for the HOT Study Group. Effects of intensive blood pressure lo0wering an low-dose aspirin in patients with hypertensive: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet. 1998;351:1756-62.
38. Haynes BR, McRibbon KA, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996; 348:383-6.
39. McIness GT. Integrated apporaches to management of hypertension: promoting treatment acceptance. Am Heart J. 1999;138:252-6.
40. Bakris GL, Weir MR, Black HR. Improving blood pressure control rates: is there more we can do? J Clin Hypertens. 2007;9:134-42.
41. Mancia G, Grassi G. Systolic and diastolic blood pressure control in atipatients drugs trials. J Hypertens. 2002;20:1461-4.
42. Hypertension Detection and Follow-up Program Cooperative Group. Five years finding of the Hypertension Detection and Follow-up Program: I. Reduction on mortality of persons with high blood pressure, incluinding mild hypertension. JAMA. 1979;242:2562-71.